294 related articles for article (PubMed ID: 30165155)
1. Irisin levels in LMNA-associated partial lipodystrophies.
Bensmaïne F; Benomar K; Espiard S; Vahe C; Le Mapihan K; Lion G; Lemdani M; Chazard E; Ernst O; Vigouroux C; Pigny P; Vantyghem MC
Diabetes Metab; 2019 Jan; 45(1):67-75. PubMed ID: 30165155
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.
Resende ATP; Martins CS; Bueno AC; Moreira AC; Foss-Freitas MC; de Castro M
Clin Endocrinol (Oxf); 2019 Jul; 91(1):94-103. PubMed ID: 30954027
[TBL] [Abstract][Full Text] [Related]
3. A new method for body fat evaluation, body adiposity index, is useful in women with familial partial lipodystrophy.
Godoy-Matos AF; Moreira RO; Valerio CM; Mory PB; Moises RS
Obesity (Silver Spring); 2012 Feb; 20(2):440-3. PubMed ID: 22095113
[TBL] [Abstract][Full Text] [Related]
4. Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.
Patni N; Li X; Adams-Huet B; Vasandani C; Gomez-Diaz RA; Garg A
J Clin Endocrinol Metab; 2019 Apr; 104(4):1099-1108. PubMed ID: 30418556
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.
Vasandani C; Li X; Sekizkardes H; Adams-Huet B; Brown RJ; Garg A
J Clin Endocrinol Metab; 2020 Jul; 105(7):2132-41. PubMed ID: 32193531
[TBL] [Abstract][Full Text] [Related]
6. A recurrent familial partial lipodystrophy due to a monoallelic or biallelic LMNA founder variant highlights the multifaceted cardiac manifestations of metabolic laminopathies.
Treiber G; Flaus Furmaniuk A; Guilleux A; Medjane S; Bonfanti O; Schneebeli S; Bernard C; Le-Moullec N; Bakiri F; Pholsena M; Rollot O; Vatier C; Jarlet E; Jéru I; Lascols O; Darcel F; Domun B; Venault A; Venault S; Jacquemont ML; Doray B; Maiza JC; Cogne M; Vigouroux C; Nobécourt E
Eur J Endocrinol; 2021 Aug; 185(4):453-462. PubMed ID: 34292171
[TBL] [Abstract][Full Text] [Related]
7. Relation of serum irisin level with metabolic and antropometric parameters in obese children.
Çatlı G; Küme T; Tuhan HÜ; Anık A; Çalan ÖG; Böber E; Abacı A
J Diabetes Complications; 2016; 30(8):1560-1565. PubMed ID: 27539885
[TBL] [Abstract][Full Text] [Related]
8. Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.
Guillín-Amarelle C; Sánchez-Iglesias S; Castro-Pais A; Rodriguez-Cañete L; Ordóñez-Mayán L; Pazos M; González-Méndez B; Rodríguez-García S; Casanueva FF; Fernández-Marmiesse A; Araújo-Vilar D
Endocrine; 2016 Nov; 54(2):411-421. PubMed ID: 27473102
[TBL] [Abstract][Full Text] [Related]
9. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents.
Jang HB; Kim HJ; Kang JH; Park SI; Park KH; Lee HJ
Metabolism; 2017 Aug; 73():100-108. PubMed ID: 28732566
[TBL] [Abstract][Full Text] [Related]
10. FPLD2 LMNA mutation R482W dysregulates iPSC-derived adipocyte function and lipid metabolism.
Friesen M; Cowan CA
Biochem Biophys Res Commun; 2018 Jan; 495(1):254-260. PubMed ID: 29108996
[TBL] [Abstract][Full Text] [Related]
11. Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series.
Zhong ZX; Harris J; Wilber E; Gorman S; Savage DB; O'Rahilly S; Stears A; Williams RM
Clin Endocrinol (Oxf); 2022 Dec; 97(6):755-762. PubMed ID: 35920656
[TBL] [Abstract][Full Text] [Related]
12. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study.
Sahin-Efe A; Upadhyay J; Ko BJ; Dincer F; Park KH; Migdal A; Vokonas P; Mantzoros C
Metabolism; 2018 Feb; 79():24-32. PubMed ID: 29108900
[TBL] [Abstract][Full Text] [Related]
13. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
14. Irisin levels in genetic and essential obesity: clues for a potential dual role.
Mai S; Grugni G; Mele C; Vietti R; Vigna L; Sartorio A; Aimaretti G; Scacchi M; Marzullo P
Sci Rep; 2020 Jan; 10(1):1020. PubMed ID: 31974460
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Dietary Intake, Leisure-Time Physical Activity, and Metabolic Profile in Women with Mutation in the LMNA Gene.
Monteiro L; Foss-Freitas MC; Navarro A; Pereira F; Coeli F; Carneseca E; Júnior RM; Foss M
J Am Coll Nutr; 2017; 36(4):248-252. PubMed ID: 28443701
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinedione response in familial lipodystrophy patients with LMNA mutations: a case series.
Luedtke A; Boschmann M; Colpe C; Engeli S; Adams F; Birkenfeld AL; Haufe S; Rahn G; Luft FC; Schmidt HH; Jordan J
Horm Metab Res; 2012 Apr; 44(4):306-11. PubMed ID: 22274718
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index.
Stengel A; Hofmann T; Goebel-Stengel M; Elbelt U; Kobelt P; Klapp BF
Peptides; 2013 Jan; 39():125-30. PubMed ID: 23219488
[TBL] [Abstract][Full Text] [Related]
18. Association of Serum Irisin Levels with Body Composition, Metabolic Profile, Leptin, and Adiponectin Levels in Lean and Obese Children.
Esin K; Batirel S; Ülfer G; Yigit P; Sanlier N
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004003
[No Abstract] [Full Text] [Related]
19. Serum concentration of adipocytokines in prepubertal vegetarian and omnivorous children.
Ambroszkiewicz J; Klemarczyk W; Gajewska J; Chełchowska M; Rowicka G; Ołtarzewski M; Laskowska-Klita T
Med Wieku Rozwoj; 2011; 15(3):326-34. PubMed ID: 22006488
[TBL] [Abstract][Full Text] [Related]
20. A novel phenotypic expression associated with a new mutation in LMNA gene, characterized by partial lipodystrophy, insulin resistance, aortic stenosis and hypertrophic cardiomyopathy.
Araújo-Vilar D; Lado-Abeal J; Palos-Paz F; Lattanzi G; Bandín MA; Bellido D; Domínguez-Gerpe L; Calvo C; Pérez O; Ramazanova A; Martínez-Sánchez N; Victoria B; Costa-Freitas AT
Clin Endocrinol (Oxf); 2008 Jul; 69(1):61-8. PubMed ID: 18031308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]